10-60043304-T-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_020987.5(ANK3):c.13066-545A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.181 in 985,230 control chromosomes in the GnomAD database, including 17,143 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.14 ( 1868 hom., cov: 32)
Exomes 𝑓: 0.19 ( 15275 hom. )
Consequence
ANK3
NM_020987.5 intron
NM_020987.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.00100
Publications
7 publications found
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
- intellectual disability-hypotonia-spasticity-sleep disorder syndromeInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
- intellectual disabilityInheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
- Tourette syndromeInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.202 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ANK3 | NM_020987.5 | c.13066-545A>C | intron_variant | Intron 42 of 43 | ENST00000280772.7 | NP_066267.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ANK3 | ENST00000280772.7 | c.13066-545A>C | intron_variant | Intron 42 of 43 | 1 | NM_020987.5 | ENSP00000280772.1 |
Frequencies
GnomAD3 genomes AF: 0.138 AC: 20964AN: 152092Hom.: 1869 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
20964
AN:
152092
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.189 AC: 157324AN: 833020Hom.: 15275 Cov.: 33 AF XY: 0.190 AC XY: 72926AN XY: 384672 show subpopulations
GnomAD4 exome
AF:
AC:
157324
AN:
833020
Hom.:
Cov.:
33
AF XY:
AC XY:
72926
AN XY:
384672
show subpopulations
African (AFR)
AF:
AC:
515
AN:
15790
American (AMR)
AF:
AC:
103
AN:
984
Ashkenazi Jewish (ASJ)
AF:
AC:
679
AN:
5154
East Asian (EAS)
AF:
AC:
227
AN:
3630
South Asian (SAS)
AF:
AC:
2293
AN:
16456
European-Finnish (FIN)
AF:
AC:
35
AN:
282
Middle Eastern (MID)
AF:
AC:
337
AN:
1622
European-Non Finnish (NFE)
AF:
AC:
148361
AN:
761802
Other (OTH)
AF:
AC:
4774
AN:
27300
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
6511
13022
19532
26043
32554
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
6964
13928
20892
27856
34820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.138 AC: 20954AN: 152210Hom.: 1868 Cov.: 32 AF XY: 0.133 AC XY: 9871AN XY: 74412 show subpopulations
GnomAD4 genome
AF:
AC:
20954
AN:
152210
Hom.:
Cov.:
32
AF XY:
AC XY:
9871
AN XY:
74412
show subpopulations
African (AFR)
AF:
AC:
1778
AN:
41566
American (AMR)
AF:
AC:
1789
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
453
AN:
3470
East Asian (EAS)
AF:
AC:
353
AN:
5182
South Asian (SAS)
AF:
AC:
611
AN:
4806
European-Finnish (FIN)
AF:
AC:
1487
AN:
10606
Middle Eastern (MID)
AF:
AC:
64
AN:
292
European-Non Finnish (NFE)
AF:
AC:
13932
AN:
67980
Other (OTH)
AF:
AC:
315
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
920
1840
2761
3681
4601
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
226
452
678
904
1130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
353
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.